Research & Publication


Research and Publications

Field of Research

Our department is pursuingresearch work in the following areas:

1.      NaturalProduct Biomolecule Analysis

2.      Haemoglobinopathies

3.      GenomicAnalysis for Various Diseases

4.      PlantTissue Culture

5.      ScientificValidation of Traditional Knowledge

6.      EnvironmentalAssessment of Heavy Metals and Their Health Hazard Impacts

7.      PharmacologicalStudy of Medicinal Plants for Various Diseases

8.      ChemokineReceptors and Their Role in Various Diseases

Research Laboratories / Cells

To support the above research areas, the department operatesthe following laboratories and cells:

1.     Molecular Biology Laboratory

2.     Genomics Laboratory

3.     Traditional Knowledge Validation Laboratory

4.     Tissue Culture Laboratory

5.     Sickle Cell Unit

6.     Instrumentation Cell

7.     Sterilization Cell

Running Projects

 

Title

Funding Agency

Budget

PI / Co-PI / Scientist

Mentor

Reference

Genetic Study of Kidney Epidemic in Supebeda Village

Research Promotion Programme, V.Y.T. PG College

5,00,000

PI: Dr. Anil Kumar

MJ/RP/01/BIT (2021)

Quantitative Analysis and Genome Expression of Redox Genes in Local Leafy Vegetables

Research Promotion Programme, V.Y.T. PG College

1,00,000

PI: Dr. Shweta Pandey; Co-PI: Dr. Nikhil Mishra

MN/RP/10/BIT (2021)

Genetic Profiling of Rare Diseases from Chhattisgarh Population

3 Billion Company, Seoul, South Korea

2,25,00,000

Dr. Anil Kumar

CEO/2021.08.23 (Extended)

 

Completed Projects

1.     Mosquito Fecundity& Malarial Infestation in Dantewada (Bastar) — DBT Govt. of India; Budget:₹8,00,000; Mentor: Dr. Anil Kumar; Ref: BT/IN/INDO-US/Foldscope/39/2015, 2018;Status: Completed.

2.     ErythrocyteDisorders Among SC/ST Population of Kabirdham District — DST; Budget:₹20,00,000; PI: Dr. Anil Kumar; Ref: NRDMS/01/23/026, June 27, 2016; Status:Completed.

3.     Association ofOral Cancer with CYP1A1 & GSTM1 Genotypes in Chhattisgarh Population —Dept. of Health Research; Budget: ₹28,38,000; PI: Dr. Madhu Pandey; Mentor: Dr.Anil Kumar; Ref: DHR/HRD/LTF1-02-2015-16, Feb 2016; Status: Completed.

4.     Prevalence ofHuman Parvovirus B19 in Sickle Cell Anemia Tribal Population — DST; Budget:₹17,44,000; Woman Scientist A: Dr. Seema Tripathi; Mentor: Dr. Anil Kumar; Ref:DST/Disha/SoRF-PM/023/2013, 2014; Status: Completed.

5.     GeneticPolymorphism of Chemokine Receptors for HIV-1 Infection in Tribal Population —DST; Budget: ₹3,25,600; Woman Scientist B: Ms. Swati Pandey; Mentor: Dr. AnilKumar; Ref: NASI/SoRF-I/2014-15/38, 2014; Status: Completed.

6.     Evaluation ofAntioxidant Properties of Medicinal Plants on Lymphocytes of Oryctolaguscuniculus — CCOST; Budget: ₹5,00,000; PI: Dr. Anil Kumar; Ref:2154/CCOST/MRP/2013, 2013; Status: Completed.

7.     Isolation &Characterization of Biomolecules from Native Plants of Chhattisgarh — CG StateMedicinal Plant Board (AYUSH); Budget: ₹1,30,44,000; PI: Dr. Anil Kumar; Ref:Res/1051, 2010; Status: Completed.

8.     Study of SickleCell Hemoglobinopathies in Chhattisgarh — UGC New Delhi; Budget: ₹10,00,000; PI:Dr. Anil Kumar; Ref: F.No. 32-s493/2006 (SR), 2007; Status: Completed.

9.     Study of SickleCell Disease and its genetic flow in Rajnandgaon & Durg districts — DSTGovt. of India; Budget: ₹10,00,000; Woman Scientist: Seema Tripathi; Mentor:Dr. Anil Kumar; Ref: SSD/SS/025/2006, 2007; Status: Completed

Publication

 

Sahu,M., Kumar, D., Kumar, S., & Kumar, A. (2025). The prevalence of chemokinereceptors (CCR5-Δ32, CCR5-m303, CCR2-64I, and SDF1-3'A) in the population withsickle cell anemia. Gene Reports, 102261.

Kumar,D., Kumar, S., Sahu, M., Pender, G. C., Govindasamy, C., Kumar, S., &Kumar, A. (2025). GC-MS identified bioactive compounds of Urena lobata L.demonstrate anti–inflammatory and immunomodulatory potentials againstrheumatoid arthritis: An in silico, in vitro and in vivo evaluation. Pharmacological Research-Natural Products6, 100152.

Kumar,D., Kumar, S., Sahu, M., Govindasamy, C., & Kumar, A. (2024). Trachelogeninfrom Urena lobata demonstrates promising potentials against SARS-CoV-2 Mpro(3CL Protease) of Endemic COVID. Journal of King Saud University-Science36(11), 103572.

Kumar,S., Kumar, D., Sahu, M., Maurya, N. S., Mani, A., Govindasamy, C., & Kumar,A. (2024). An in vitro and in silico antidiabetic approach of GC–MS detectedfriedelin of Bridelia retusa. Journal of King Saud University-Science36(10), 103411.

Kumar,A. (2024). Machine learning for Markov modeling of COVID-19 dynamics concerningair quality index, PM-2.5, NO2, PM-10, and O3. Journal homepage: http://iieta. org/journals/ijcmem12(2), 121-134.

Mishra,N., Tripathi, S., Nahar, L., Sarker, S. D., & Kumar, A. (2024). Mitigationof arsenic poisoning induced oxidative stress and genotoxicity by Ocimumgratissimum L. Toxicon238, 107603.

Singh,E., Shivwanshi, L. R., & Kumar, A. (2024). A positive correlation betweenmutated gene of sickle cell anemia and glucose-6-phosphate dehydrogenase amonggond tribes of Chhattisgarh, India. Mutation Research-Fundamental and Molecular Mechanisms ofMutagenesis828, 111849.

Zeb,A., Khan, I. U., Tripathi, S., Sahu, M. R., & Kumar, A. (2023). AnInappropriate Rise in NO2 During the COVID-19 Pandemic in the Urban Area ofChhattisgarh, India. Nature Environment and Pollution Technology22(2), 671-680.

Kumar,A., Kumar, S., & Jain, N. (2023). Impact of Increasing Climatic Temperatureon Crop Yield. Mol. Biol. Plant Physiol33(3).

Singhal, S., Bhadana, R., Jain,B. P., Gautam, A., Pandey, S., & Rani, V. (2024). Role of gut microbiota intumorigenesis and antitumoral therapies: an updated review. Biotechnology andGenetic Engineering Reviews, 40(4), 3716–3742.https://doi.org/10.1080/02648725.2023.2166268




COLLABORATIONS

 

S. No.

Title of collaborative work

Name of the collaborating agency with contact details

Name of Foreign Participants

Name of Departmental Paeticipants

1.       

Scientific validation of traditional knowledge related to medicinal plants.

Liverpool John Moores University, UK

Prof. Lutfan Nahar
Liverpool John Moores University, UK

Prof. Anil Kumar

2.       

Evaluation of Arsenic Toxicity.

 University of Kira Zula-Natal Durban, South Africa.

Prof. S.B. Jonnalogadda, University of Kira Zula-Natal Durban, South Africa.

Prof. Anil Kumar

3.       

Mathematical Modelling of COVID-19.

COMSATS University, Islamabad, Pakistan

Dr. Anwar Zeb COMSATS University, Islamabad, Pakistan

Prof. Anil Kumar

4.       

 Nanoparticle Study

School of Biotechnology, Kongwon National Univerisity, South Korea.

A.V.A. Mariadoss& M.H. Wang School of Biotechnology, Kongwon National Univerisity, South Korea.

Prof. Anil Kumar

5

Secondary Metabolites Characterization

Institute of Experimental Botany, ASCR &Palacky University Czech Republic

Lutfan Nahar Institute of Experimental Botany, ASCR &Palacky University Czech Republic

Prof. Anil Kumar

6

In silico MD Simulation for Drug Designing

Department of System Biology and Bioinformatics, University of Rostock, 18051 Rostock, Germany

Dr. Shailendra K. Gupta

Senior Scientist and Group Leader, University of Rostock, 18051 Rostock, Germany

Prof. Anil Kumar

7

Bilateral Research under Fellowship

Far Western University, Faculty of Science and Technology, Mahendranagar, Kachanpur, Nepal

Prof. Bhawani Chand Thakuri, Dean,

Far Western University, Faculty of Science and Technology, Mahendranagar, Kachanpur, Nepal

Prof. Anil Kumar